BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 23, 2009
View Archived Issues
GABA-A alpha5 inverse agonists show potential in the treatment of cognitive dysfunction
Read More
Preclinical evaluation of novel selective Nav1.8 modulators as potential analgesic agents
Read More
Sanofi-aventis signs licensing agreement for Wellstat's insulin sensitizer PN-2034
Read More
Teva reports results from phase III trial of MediWound's Debrase for burns
Read More
Affiris reports results from phase I studies of its two Alzheimer's disease vaccines
Read More
BLISS-52 study shows significant benefit with belimumab in SLE
Read More
Further clinical data on dapagliflozin presented at the World Diabetes Congress
Read More
Non-selective opioid modulator RDC-5768 reduces behavioral effects of drugs of abuse
Read More
Rolapitant similar to ondansetron in treating postoperative nausea and vomiting
Read More
Aminophylline reverses midazolam sedation in healthy volunteers
Read More
AMR-MCH-14 reduces food intake and body fat in preclinical model of obesity
Read More
The GnRH antagonist TAK-38 has potential for the treatment of endometriosis
Read More
SciClone enrolls first patient in phase II SCV-07 trial in HCV
Read More
FDA grants fast track designation to MacuSight's ocular sirolimus drug Perceiva for DME
Read More
FDA accepts for review ProStrakan's refiled NDA for Cellegesic for chronic anal fissures
Read More
Teijin signs exclusive sublicense agreement for TMX-67 with Ipsen and Menarini
Read More
Northwest reports follow-up data from phase I and I/II trials of DCVax-Brain in GBM
Read More
Sosei presents update on clinical development of NVA-237 and QVA-149 for COPD
Read More
Millennium initiates phase II trial of bortezomib in non-GCB diffuse large B-cell lymphoma
Read More
Chugai and Taisho file NDA in Japan for eldecalcitol for osteoporosis
Read More
Isis reports results from phase II study of ISIS-113715 in type 2 diabetes
Read More
Arpida withdraws MAA for iclaprim for cSSTI following CHMP's negative opinion
Read More
Dainippon Sumitomo Pharma and Sepracor successfully complete acquisition
Read More
Novartis granted E.U. approval for Exforge HCT for high blood pressure
Read More
Boehringer Ingelheim discloses CB2 receptor agonists for the treatment of pain
Read More
Merck KGaA describes glucokinase activators for the treatment of diabetes
Read More
University of California claims IRES inhibitors for the treatment of HCV infection
Read More